# Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients

> **NCT04445337** · PHASE1 · TERMINATED · sponsor: **University of Nebraska** · enrollment: 1 (actual)

## Conditions studied

- COVID 19
- ARDS

## Interventions

- **DRUG:** Stellate Ganglion Block

## Key facts

- **NCT ID:** NCT04445337
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-15
- **Primary completion:** 2021-10-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Unable to recruit sufficient number of subjects.
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04445337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04445337, "Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04445337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*